Dow Down 0.95% Nasdaq Down 0.91%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
14.42 Up 0.67(4.87%) 11:45AM EDT - Nasdaq Real Time Price
Prev Close:13.75
Open:13.88
Bid:14.43 x 700
Ask:14.46 x 300
1y Target Est:23.58
Beta:4.16
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:13.80 - 14.63
52wk Range:8.61 - 18.48
Volume:1,161,848
Avg Vol (3m):2,379,910
Market Cap:1.32B
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXUp 4.87%1.32B
BAXDown 0.42%38.71B
SHPGDown 0.39%50.44B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):126.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback